Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma
- PMID: 16215538
- DOI: 10.1038/sj.eye.6702125
Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma
Abstract
Aims: To evaluate the surgical success results of Ahmed glaucoma valve (AGV) and Molteno single-plate implant (MSPI) in cases of neovascular glaucoma (NVG).
Methods: Between May 1997 and May 2002, 38 of 38 NVG patients that underwent implantation of AGV and 27 eyes of 27 NVG patients that underwent MSPI (a total 65 eyes of 65 patients) included to the study.
Results: The cumulative probabilities of success were 63.2% at 1 year, 56.2% at 2 years, 43.2% at 3 years, 37.8% at 4 years, and 25.2% at 5 years in AGV group whereas the cumulative probabilities of success were 37.0% at 1 year, 29.6% at 2 years, 29.6% at 3 years, 29.6% at 4 years, and 29.6% at 5 years in MSPI group (P=0.141). Preoperative visual acuity <2/200 (P=0.003), diagnosis of diabetes mellitius (P=0.050), and preoperative IOP>or=35 mmHg (P=0.038) were found to be poor prognostic factors for surgical success.
Conclusions: Both AGV and single plate MSPI were successful for early and intermediate-term of IOP control but in long term both implants were failed to achieve control of IOP in patients with NVG.
Similar articles
-
A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up.J Glaucoma. 2009 Mar;18(3):192-6. doi: 10.1097/IJG.0b013e31817d235c. J Glaucoma. 2009. PMID: 19295370
-
Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.Ophthalmology. 2008 Jul;115(7):1141-7. doi: 10.1016/j.ophtha.2007.10.034. Epub 2007 Dec 27. Ophthalmology. 2008. PMID: 18164068
-
Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas.Am J Ophthalmol. 2007 Dec;144(6):893-900. doi: 10.1016/j.ajo.2007.07.035. Epub 2007 Oct 4. Am J Ophthalmol. 2007. PMID: 17916318
-
Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1079-1089. doi: 10.1007/s00417-019-04256-8. Epub 2019 Feb 6. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30726529
-
A systematic review and meta-analysis of randomised controlled trials in the management of neovascular glaucoma: absence of consensus and variability in practice.Graefes Arch Clin Exp Ophthalmol. 2023 Feb;261(2):477-501. doi: 10.1007/s00417-022-05785-5. Epub 2022 Aug 8. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 35939118 Free PMC article.
Cited by
-
Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma.PLoS One. 2015 Aug 14;10(8):e0135766. doi: 10.1371/journal.pone.0135766. eCollection 2015. PLoS One. 2015. PMID: 26275060 Free PMC article.
-
Surgical outcomes of different Ahmed Glaucoma Valve implantation methods between scleral graft and scleral flap.Korean J Ophthalmol. 2011 Oct;25(5):317-22. doi: 10.3341/kjo.2011.25.5.317. Epub 2011 Sep 20. Korean J Ophthalmol. 2011. PMID: 21976938 Free PMC article.
-
Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems.Molecules. 2019 Oct 22;24(20):3805. doi: 10.3390/molecules24203805. Molecules. 2019. PMID: 31652593 Free PMC article. Review.
-
Anti-vascular endothelial growth factor for neovascular glaucoma.Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4. Cochrane Database Syst Rev. 2023. PMID: 37010901 Free PMC article.
-
Ahmed Glaucoma Valve Implantation in Vitrectomized Eyes.J Ophthalmol. 2018 May 10;2018:9572805. doi: 10.1155/2018/9572805. eCollection 2018. J Ophthalmol. 2018. PMID: 29862068 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources